Inspire Medical Systems, Inc. (INSP)
- Previous Close
234.19 - Open
231.41 - Bid 224.00 x 1100
- Ask 235.31 x 800
- Day's Range
224.06 - 231.68 - 52 Week Range
123.27 - 330.00 - Volume
204,802 - Avg. Volume
504,654 - Market Cap (intraday)
6.999B - Beta (5Y Monthly) 1.40
- PE Ratio (TTM)
-- - EPS (TTM)
-0.73 - Earnings Date May 7, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
254.88
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
www.inspiresleep.comRecent News: INSP
Performance Overview: INSP
Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: INSP
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: INSP
Valuation Measures
Market Cap
7.10B
Enterprise Value
6.66B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
10.98
Price/Book (mrq)
12.39
Enterprise Value/Revenue
10.66
Enterprise Value/EBITDA
-390.38
Financial Highlights
Profitability and Income Statement
Profit Margin
-3.39%
Return on Assets (ttm)
-4.05%
Return on Equity (ttm)
-3.96%
Revenue (ttm)
624.8M
Net Income Avi to Common (ttm)
-21.15M
Diluted EPS (ttm)
-0.73
Balance Sheet and Cash Flow
Total Cash (mrq)
460.38M
Total Debt/Equity (mrq)
4.34%
Levered Free Cash Flow (ttm)
380.62k